MDXHEALTH Pricing & Demo

Are you from this Company?
MDXHEALTH
Write a Review
Herstal, Belgium
2003
$51MN to $100MN
Enterprise
52 Likes
70 Buyers Negotiating
Summary
No Summary And Details

Popular Comparisons

Discussions

Strengths
  • +13
    Clinical Use
  • +14
    Assay kits
  • +9
    Circulating Tumor Cells (CTCs)
  • +5
    Instruments
  • +12
    Research Use
  • +8
    Urine
  • +6
    Treatment Monitoring
  • +14
    Breadth and Depth of Product Offerings
  • +6
    Focus on Product Innovation
  • +5
    Product Features and Functionality
  • +7
    Product Differentiation and Impact on Customer Value
  • +9
    Others (Saliva, other body fluids)
  • +8
    New Liquid Biopsy Products launched in the last four years
  • +5
    Therapy Selection
  • +7
    Blood
  • +10
    Circulating Tumor DNA (ctDNA)
  • +11
    Cell-Free DNA (cfDNA)
  • +12
    Extracellular Vesicles (EVs)
  • +14
    Early Cancer Screening
  • +13
    Other Circulating Biomarkers
Cautions
  • -7
    Recurrence Monitoring
  • -6
    Services
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup
logo-360
  • Home
  • About Us
  • Industries
  • Companies
  • saved

    You haven’t saved anything yet

    To save, search for Vendors by
    Name or Category, then tap the heart

360 quadrants

360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets

Connect
© 2026 360Quadrants, All rights reserved.